<br /> Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial – Fingerprint<br /> — University of Edinburgh Research Explorer


Medicine & Life Sciences

Source link